Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Rotavirus vaccination within the South African Expanded Programme on Immunisation.

Seheri LM, Page NA, Mawela MP, Mphahlele MJ, Steele AD.

Vaccine. 2012 Sep 7;30 Suppl 3:C14-20. doi: 10.1016/j.vaccine.2012.04.018. Review.

PMID:
22939015
2.

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD.

Vaccine. 2012 Apr 27;30 Suppl 1:A44-51. doi: 10.1016/j.vaccine.2011.08.080.

PMID:
22520136
3.

Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.

Pawinski R, Debrus S, Delem A, Smolenov I, Suryakiran PV, Han HH.

J Infect Dis. 2010 Sep 1;202 Suppl:S80-6. doi: 10.1086/653547.

PMID:
20684722
4.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
5.

Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium.

Parashar U, Steele D, Neuzil K, Quadros Cd, Tharmaphornpilas P, Serhan F, Santosham M, Patel M, Glass R.

Expert Rev Vaccines. 2013 Feb;12(2):113-7. doi: 10.1586/erv.12.148.

PMID:
23414403
6.

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.

Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, Tate J, Parashar U, Patel M.

Int J Infect Dis. 2010 Jul;14(7):e592-5. doi: 10.1016/j.ijid.2009.08.014. Epub 2009 Dec 22.

7.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
8.

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.

Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.

Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Review.

PMID:
22309669
9.

Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.

Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML.

Pediatr Infect Dis J. 2010 Nov;29(11):1019-22. doi: 10.1097/INF.0b013e3181e7886a.

PMID:
20543761
10.

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.

Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, Patel M, Parashar U, Lopman B.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S200-7. doi: 10.1093/cid/ciw014.

PMID:
27059357
11.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1. Review.

12.

Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.

Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM.

Vaccine. 2012 Apr 27;30 Suppl 1:A24-9. doi: 10.1016/j.vaccine.2011.08.124.

PMID:
22520132
13.

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.

Tate JE, Ngabo F, Donnen P, Gatera M, Uwimana J, Rugambwa C, Mwenda JM, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S208-12. doi: 10.1093/cid/civ1016.

PMID:
27059358
14.

Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.

Groome MJ, Zell ER, Solomon F, Nzenze S, Parashar UD, Izu A, Madhi SA.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S188-95. doi: 10.1093/cid/civ1204.

PMID:
27059355
15.

Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.

Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD.

Vaccine. 2012 Apr 27;30 Suppl 1:A79-85. doi: 10.1016/j.vaccine.2012.01.022.

PMID:
22520141
16.

Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.

Nakagomi O, Iturriza-Gomara M, Nakagomi T, Cunliffe NA.

Expert Opin Biol Ther. 2013 Nov;13(11):1613-21. doi: 10.1517/14712598.2013.840285. Epub 2013 Oct 2. Review.

PMID:
24088009
17.
18.

Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.

Mpabalwani EM, Simwaka CJ, Mwenda JM, Mubanga CP, Monze M, Matapo B, Parashar UD, Tate JE.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S183-7. doi: 10.1093/cid/civ1027.

PMID:
27059354
19.

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.

Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM.

Mem Inst Oswaldo Cruz. 2011 Dec;106(8):907-11. Review.

20.

Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.

Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S, Asoyan A, Gevorgyan Z, Kocharyan K, Avagyan T, Lopman B, Vanyan A, Khactatryan S, Parashar UD, Cortese MM.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S147-54. doi: 10.1093/cid/ciw045.

PMID:
27059349

Supplemental Content

Support Center